Schroder Investment Management Group’s Kymera Therapeutics KYMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$3.44M	Sell	43,243 -9,428	-18%	-$747K	﹤0.01%	840
2025 Q4	$4.11M	Sell	52,671 -8,969	-15%	-$606K	﹤0.01%	783
2025 Q3	$3.61M	Sell	61,640 -48,573	-44%	-$2.19M	﹤0.01%	827
2025 Q2	$4.81M	Sell	110,213 -48,125	-30%	-$1.66M	﹤0.01%	769
2025 Q1	$4.69M	Sell	158,338 -5,558	-3%	-$203K	﹤0.01%	766
2024 Q4	$6.44M	Buy	163,896 +20,204	+14%	+$913K	0.01%	725
2024 Q3	$7M	Sell	143,692 -18,509	-11%	-$817K	0.01%	732
2024 Q2	$4.84M	Buy	162,201 +41,354	+34%	+$1.43M	0.01%	789
2024 Q1	$4.86M	Sell	120,847 -64,452	-35%	-$2.31M	0.01%	786
2023 Q4	$4.72M	Sell	185,299 -42,281	-19%	-$756K	0.01%	775
2023 Q3	$3.16M	Buy	227,580 +2,749	+1%	+$55.3K	﹤0.01%	839
2023 Q2	$5.17M	Buy	+224,831	New	+$6.44M	0.01%	778
2022 Q1	–	Sell	-28,989	Closed	-$1.84M	–	1480
2021 Q4	$1.84M	Buy	+28,989	New	+$1.69M	﹤0.01%	944